FourWorld Capital Management’s Tevogen Inc. Warrant TVGNW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.55M Hold
1,450,000
3.34% 4
2025
Q4
$480K Hold
1,450,000
0.39% 21
2025
Q3
$79.8K Hold
1,450,000
0.13% 24
2025
Q2
$101K Hold
1,450,000
0.07% 22
2025
Q1
$78.2K Hold
1,450,000
0.05% 22
2024
Q4
$78.3K Hold
1,450,000
0.04% 20
2024
Q3
$18.7K Hold
1,450,000
0.01% 27
2024
Q2
$299K Hold
1,450,000
0.18% 23
2024
Q1
$5.44M Hold
1,450,000
3.47% 9
2023
Q4
$16.1M Hold
1,450,000
8.69% 4
2023
Q3
$72.5K Hold
1,450,000
0.01% 23
2023
Q2
$59.9K Hold
1,450,000
0.01% 23
2023
Q1
$116K Hold
1,450,000
0.03% 20
2022
Q4
$10.9K Hold
1,450,000
0.02% 18
2022
Q3
$174K Hold
1,450,000
0.28% 11
2022
Q2
$232K Buy
1,450,000
+1,160,000
+400% +$274K 0.37% 11
2022
Q1
$78K Buy
+290,000
New +$108K 0.05% 12

Other funds holding TVGNW

FourWorld Capital Management's TVGNW Position: Q1 2026 in Review

FourWorld Capital Management held its Tevogen Inc. Warrant (TVGNW) position steady in Q1 2026 at 1,450,000 shares worth $6.55M. The position accounts for 3.34% of the portfolio, ranked #4.

FourWorld Capital Management first reported a position in TVGNW in Q1 2022 and has held it in 17 quarters since. The position peaked at $16.1M in Q4 2023. 33 funds tracked by Wall St. Rank hold TVGNW as of Q1 2026.

  • FourWorld Capital Management held 1,450,000 shares of Tevogen Inc. Warrant worth $6.55M as of Q1 2026.
  • FourWorld Capital Management left its Tevogen Inc. Warrant share count unchanged in Q1 2026.
  • Tevogen Inc. Warrant made up 3.34% of FourWorld Capital Management's portfolio in Q1 2026, its #4 holding.
  • FourWorld Capital Management first reported a position in Tevogen Inc. Warrant in Q1 2022 and has held it in 17 quarters since.
  • FourWorld Capital Management's Tevogen Inc. Warrant position peaked at $16.1M in Q4 2023.
  • 33 funds tracked by Wall St. Rank held Tevogen Inc. Warrant as of Q1 2026.

Based on FourWorld Capital Management's 13F filing for Q1 2026, filed 15 May 2026.